14-3-3σ regulates β-catenin-mediated mouse embryonic stem cell proliferation by sequestering GSK-3β

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Chang, Tzu Ching ^a   Liu, Chia Chia ^a,b   Hsing, En Wei ^a   Liang, Shu Man ^a   Chi, Ya Hui ^a   Sung, Li Ying ^b   Lin, Shau Ping ^b   Shen, Tang Long ^b   Ko, Bor Sheng ^a,c   Yen, B Linju ^a   Yet, Shaw Fang ^a   Wu, Kenneth K ^a   Liou, Jun Yang ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DICKKOPF 1 PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN 14 3 3; PROTEIN 14 3 3 BETA; PROTEIN 14 3 3 EPSILON; PROTEIN 14 3 3 ETA; PROTEIN 14 3 3 GAMMA; PROTEIN 14 3 3 THETA; PROTEIN KINASE B; RETINOIC ACID; SMALL INTERFERING RNA; STRATIFIN; UNCLASSIFIED DRUG; WNT3A PROTEIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENZYME PHOSPHORYLATION; GENE SILENCING; GENETIC TRANSFECTION; GROWTH INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

14-3-3 PROTEINS; ANIMALS; AXIN PROTEIN; BETA CATENIN; CELL NUCLEUS; CELL PROLIFERATION; EMBRYONIC STEM CELLS; GLYCOGEN SYNTHASE KINASE 3; MICE; MODELS, BIOLOGICAL; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; PROTEIN STABILITY; PROTEIN TRANSPORT; RNA, SMALL INTERFERING; WNT PROTEINS;

EID: 84863112758     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040193     Document Type: Article

References (44)

1. Evans MJ, Kaufman MH, (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154-156.
2. Martin GR, (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 78: 7634-7638.
3. Bouhon IA, Joannides A, Kato H, Chandran S, Allen ND, (2006) Embryonic stem cell-derived neural progenitors display temporal restriction to neural patterning. Stem Cells 24: 1908-1913.
4. Sakurai H, Okawa Y, Inami Y, Nishio N, Isobe K, (2008) Paraxial mesodermal progenitors derived from mouse embryonic stem cells contribute to muscle regeneration via differentiation into muscle satellite cells. Stem Cells 26: 1865-1873.
5. Liu N, Lu M, Tian X, Han Z, (2007) Molecular mechanisms involved in self-renewal and pluripotency of embryonic stem cells. J Cell Physiol 211: 279-286.
6. Okita K, Yamanaka S, (2006) Intracellular signaling pathways regulating pluripotency of embryonic stem cells. Curr Stem Cell Res Ther 1: 103-111.
7. Katoh M, (2007) WNT signaling pathway and stem cell signaling network. Clin Cancer Res 13: 4042-4045.
8. Kleber M, Sommer L, (2004) Wnt signaling and the regulation of stem cell function. Curr Opin Cell Biol 16: 681-687.
9. Doble BW, Woodgett JR, (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116: 1175-1186.
10. Nelson WJ, Nusse R, (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483-1487.
11. Zeng X, Tamai K, Doble B, Li S, Huang H, et al. (2005) A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 438: 873-877.
12. Aubert J, Dunstan H, Chambers I, Smith A, (2002) Functional gene screening in embryonic stem cells implicates Wnt antagonism in neural differentiation. Nat Biotechnol 20: 1240-1245.
13. Kielman MF, Rindapaa M, Gaspar C, van Poppel N, Breukel C, et al. (2002) Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nat Genet 32: 594-605.
14. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH, (2004) Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10: 55-63.
15. Welsh GI, Wilson C, Proud CG, (1996) GSK3: a SHAGGY frog story. Trends Cell Biol 6: 274-279.
16. Fu H, Subramanian RR, Masters SC, (2000) 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40: 617-647.
17. Morrison DK, (2009) The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol 19: 16-23.
18. Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, et al. (1997) The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91: 961-971.
19. Agarwal-Mawal A, Qureshi HY, Cafferty PW, Yuan Z, Han D, et al. (2003) 14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex. J Biol Chem 278: 12722-12728.
20. Mwangi S, Anitha M, Fu H, Sitaraman SV, Srinivasan S, (2006) Glial cell line-derived neurotrophic factor-mediated enteric neuronal survival involves glycogen synthase kinase-3beta phosphorylation and coupling with 14-3-3. Neuroscience 143: 241-251.
21. Tian Q, Feetham MC, Tao WA, He XC, Li L, et al. (2004) Proteomic analysis identifies that 14-3-3zeta interacts with beta-catenin and facilitates its activation by Akt. Proc Natl Acad Sci U S A 101: 15370-15375.
22. Li FQ, Mofunanya A, Harris K, Takemaru K, (2008) Chibby cooperates with 14-3-3 to regulate beta-catenin subcellular distribution and signaling activity. J Cell Biol 181: 1141-1154.
23. Chang TC, Chen YC, Yang MH, Chen CH, Hsing EW, et al. (2010) Rho kinases regulate the renewal and neural differentiation of embryonic stem cells in a cell plating density-dependent manner. PLoS One 5: e9187.
24. Liou JY, Ellent DP, Lee S, Goldsby J, Ko BS, et al. (2007) Cyclooxygenase-2-derived prostaglandin e2 protects mouse embryonic stem cells from apoptosis. Stem Cells 25: 1096-1103.
25. Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R, (1985) The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87: 27-45.
26. Wood SA, Allen ND, Rossant J, Auerbach A, Nagy A, (1993) Non-injection methods for the production of embryonic stem cell-embryo chimaeras. Nature 365: 87-89.
27. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, et al. (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275: 1784-1787.
28. Wilker EW, Grant RA, Artim SC, Yaffe MB, (2005) A structural basis for 14-3-3sigma functional specificity. J Biol Chem 280: 18891-18898.
29. Yang HY, Wen YY, Chen CH, Lozano G, Lee MH, (2003) 14-3-3 sigma positively regulates p53 and suppresses tumor growth. Mol Cell Biol 23: 7096-7107.
30. Liu P, Yang J, Pei J, Pei D, Wilson MJ, (2010) Regulation of MT1-MMP activity by beta-catenin in MDCK non-cancer and HT1080 cancer cells. J Cell Physiol 225: 810-821.
31. Yan W, Tai HH, (2006) Glycogen synthase kinase-3 phosphorylation, T-cell factor signaling activation, and cell morphology change following stimulation of thromboxane receptor alpha. J Pharmacol Exp Ther 317: 267-274.
32. Zhou BP, Deng J, Xia W, Xu J, Li YM, et al. (2004) Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6: 931-940.
33. Ko BS, Chang TC, Shyue SK, Chen YC, Liou JY, (2009) An efficient transfection method for mouse embryonic stem cells. Gene Ther 16: 154-158.
34. Liou JY, Ko BS, Chang TC, (2010) An efficient transfection method for mouse embryonic stem cells. Methods Mol Biol 650: 145-153.
35. Liou JY, Ghelani D, Yeh S, Wu KK, (2007) Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3epsilon. Cancer Res 67: 3185-3191.
36. Ding Q, He X, Xia W, Hsu JM, Chen CT, et al. (2007) Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer. Cancer Res 67: 4564-4571.
37. Ishiguro K, Shiratsuchi A, Sato S, Omori A, Arioka M, et al. (1993) Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett 325: 167-172.
38. Duester G, (2008) Retinoic acid synthesis and signaling during early organogenesis. Cell 134: 921-931.
39. Martin-Ibanez R, Urban N, Sergent-Tanguy S, Pineda JR, Garrido-Clua N, et al. (2007) Interplay of leukemia inhibitory factor and retinoic acid on neural differentiation of mouse embryonic stem cells. J Neurosci Res 85: 2686-2701.
40. Su YW, Hao Z, Hirao A, Yamamoto K, Lin WJ, et al. (2011) 14-3-3sigma regulates B-cell homeostasis through stabilization of FOXO1. Proc Natl Acad Sci U S A 108: 1555-1560.
41. Fantl WJ, Muslin AJ, Kikuchi A, Martin JA, MacNicol AM, et al. (1994) Activation of Raf-1 by 14-3-3 proteins. Nature 371: 612-614.
42. Li S, Janosch P, Tanji M, Rosenfeld GC, Waymire JC, et al. (1995) Regulation of Raf-1 kinase activity by the 14-3-3 family of proteins. EMBO J 14: 685-696.
43. Li Y, Inoki K, Yeung R, Guan KL, (2002) Regulation of TSC2 by 14-3-3 binding. J Biol Chem 277: 44593-44596.
44. Shumway SD, Li Y, Xiong Y, (2003) 14-3-3beta binds to and negatively regulates the tuberous sclerosis complex 2 (TSC2) tumor suppressor gene product, tuberin. J Biol Chem 278: 2089-2092.